APA (7th ed.) Citation

Ü, A., M, K., & HM, B. D. (2026). HER2-Low Versus HER2-Zero Breast Cancer in the Neoadjuvant Setting: Pathological Complete Response and Exploratory Survival Outcomes in a Single-Center Cohort. Medicina (Kaunas, Lithuania), 62(7), . https://doi.org/10.3390/medicina62071261

Chicago Style (17th ed.) Citation

Ü, Ateş, Keskinkılıç M, and Binnaz Demirkan HM. "HER2-Low Versus HER2-Zero Breast Cancer in the Neoadjuvant Setting: Pathological Complete Response and Exploratory Survival Outcomes in a Single-Center Cohort." Medicina (Kaunas, Lithuania) 62, no. 7 (2026). https://doi.org/10.3390/medicina62071261.

MLA (9th ed.) Citation

Ü, Ateş, et al. "HER2-Low Versus HER2-Zero Breast Cancer in the Neoadjuvant Setting: Pathological Complete Response and Exploratory Survival Outcomes in a Single-Center Cohort." Medicina (Kaunas, Lithuania), vol. 62, no. 7, 2026, https://doi.org/10.3390/medicina62071261.